The government agency is warning against drinking so-called “Miracle” or “Master” Mineral Solutions, which are actually bleach.
The U.S. Food and Drug Administration has issued a warning to consumers against drinking mineral solutions that contain sodium chlorite. The miracle drinks are marketed online as a cure-all for everything from flu to cancer. Consumers purchase the solution online and then mix it with lemon juice or an activator. The final product is a chemical that could be used as bleach.
The FDA is issuing a new warning after it received reports of consumers getting very sick from drinking miracle and master solutions. The agency warned consumers about the solutions back in 2010, but the products still have a strong presence on the internet. The solutions go by names including miracle or master solution, chlorine dioxide protocol (CD), morale mineral supplement, MMS and water purification solution (WPS).
Sellers of these solutions claim it is an antimicrobial, antiviral, or antibacterial treatment that can cure autism, hepatitis, flu, cancer, HIV/AIDS, and more. These claims have not been found valid by the FDA and can make a person very ill. The FDA has received reports that these products have caused severe vomiting and diarrhea, life-threatening low blood pressure, and acute liver failure.
Some retailers have gone as far as to say that diarrhea and vomiting are signs the solution is working. The FDA wants to to be clear: sodium chlorite products are dangerous, and they should not be consumed by anyone.
“The FDA’s drug approval process ensures that patients receive safe and effective drug products. Miracle Mineral Solution and similar products are not FDA-approved, and ingesting these products is the same as drinking bleach. Consumers should not use these products, and parents should not give these products to their children for any reason,” said FDA Acting Commissioner Ned Sharpless, M.D.
If you get sick from drinking a sodium chlorite solution, you should seek medical attention right away and report the illness to the FDA’s MedWatch Safety Information and Adverse Reporting Program.